Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury

Ischemic Heart Disease (IHD) is the main global cause of death. Previous studies indicated that recombinant human secretory leukocyte protease inhibitor (rhSLPI) exhibits a cardioprotective effect against myocardial ischaemia/reperfusion (I/R) injury. However, SLPI has a short half-life in vivo due...

Descripció completa

Dades bibliogràfiques

Autors principals:	Faprathan Pikwong, Chayanisa Phutiyothin, Wannapat Chouyratchakarn, Phornsawat Baipaywad, Podsawee Mongkolpathumrat, Sarawut Kumphune
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-09-01
Col·lecció:	Heliyon
Matèries:	Secretory leukocyte protease inhibitor (SLPI) Gelatin-covered silica nanoparticles Nanoparticles Ischaemia and reperfusion (I/R) injury
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2405844023073589
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!